arrow
F

Ferdinando Squitieri

Fondazione IRCCS Casa Sollievo della Sofferenza
H指数:61
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and efficacy of SOM3355 in patients with Huntington’s disease (SOMCT03): a phase 2b, randomised, placebo-controlled, multicentre, dose-ranging study

SOM3355在亨廷顿病患者的安全性与有效性(SOMCT03):一项2b期、随机、安慰剂对照、多中心、剂量范围研究

2026-09-280
OAAI
Development and validation of the first needs-based quality of life measure for individuals with manifest Huntington’s disease

基于需求的显性亨廷顿病患者生活质量评估工具的开发与验证

2026-06-110
OA
GLUT-1 changes in paediatric Huntington disease brain cortex and fibroblasts: an observational case-control study

儿童亨廷顿病大脑皮质和成纤维细胞中GLUT-1的变化: 一项观察性病例对照研究

2023-11-017
OAAI
Validity, diagnostics and feasibility of the Italian version of the Montreal Cognitive Assessment (MoCA) in Huntington's disease

意大利语版本的蒙特利尔认知评估 (MoCA) 在亨廷顿氏病中的有效性,诊断性和可行性

2023-09-281
PRE
Semiology and determinants of apathy across neurodegenerative motor disorders: A comparison between amyotrophic lateral sclerosis, Parkinson's and Huntington's disease

跨神经退行性运动障碍的冷漠的符号学和决定因素: 肌萎缩性侧索硬化症,帕金森氏病和亨廷顿氏病之间的比较

2022-11-022
OAAI
FAULTY LINEAR AND BACK-SPLICING IN HUNTINGTON'S DISEASE: NOVEL PLAYERS IN THE PATHOLOGIC PROCESS HINT AT INNOVATIVE RNA BIOMARKERS
2022-09-120
PRE